Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Pain and Therapy|October 17, 2025
Bimekizumab Pain Outcomes in Patients with Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II Phase 3 Randomized Clinical TrialsJohn R Ingram, Hideki Fujita, Alice B Gottlieb, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 14, 2022
Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn's Disease PatientsMatt Kanke, Meaghan M Kennedy Ng, Sean Connelly, et al.
JAMA Dermatology|July 26, 2023
Genetic Variants Associated With Hidradenitis SuppurativaQuan Sun, K Alaine Broadaway, Sharon N Edmiston, et al.
Scientific Reports|June 30, 2021
Increased colonic expression of ACE2 associates with poor prognosis in Crohn's diseaseTakahiko Toyonaga, Kenza C Araba, Meaghan M Kennedy, et al.
Gastroenterology|January 27, 2015
Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening populationDouglas K Rex, Samuel N Adler, James Aisenberg, et al.
Lancet (London, England)|May 25, 2024
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Christopher J Sayed, et al.
The British Journal of Dermatology|November 17, 2023
Global consensus process to establish a core dataset for hidradenitis suppurativa registriesHannah E Wainman, Nisha S Chandran, John W Frew, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2020
Increased Colonic Expression of ACE2 Associates with Poor Prognosis in Crohn's diseaseTakahiko Toyonaga, Kenza C Araba, Meaghan M Kennedy, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 21, 2020
Decreased Colonic Activin Receptor-Like Kinase 1 Disrupts Epithelial Barrier Integrity in Patients With Crohn's DiseaseTakahiko Toyonaga, Erin C Steinbach, Benjamin P Keith, et al.
Gastroenterology|July 3, 2018
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative ColitisHans Herfarth, Edward L Barnes, John F Valentine, et al.
Pageof 9